Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients

Expiratory flow limitation (EFL), which promotes dynamic hyperinflation and increased work of breathing, often occurs in chronic obstructive pulmonary disease (COPD). The purpose of this study was to assess the effect of bronchodilators on EFL and end-expiratory lung volume in patients with moderate-to-severe COPD. EFL was assessed by applying negative expiratory pressure (NEP) at the mouth during tidal expiration. EFL was present when expiratory flow did not increase or increased only in the early phase of expiration with NEP. In 18 patients (age 65+/-2 yrs; forced expiratory volume in one second (FEV1)=45+/-4% predicted) pulmonary function tests and a series of NEP (-3.5 cmH2O) test breaths were performed at rest in a sitting position before and 20 min after inhalation of 400 microg of salbutamol. EFL was detected in 11 patients and persisted after salbutamol in all of these flow-limited (FL) patients. After bronchodilator administration FL patients exhibited a significant decrease in functional residual capacity (FRC) associated with an increase in inspiratory capacity (IC). In contrast, no changes in FRC and IC were observed in the seven non flow-limited (NFL) patients after administration of salbutamol. Except for one NFL patient, the other 17 patients (six NFL and 11 FL) had no reversibility of their bronchial obstruction (delta FEV1 <10% pred). In conclusion, patients with chronic obstructive pulmonary disease and expiratory flow limitation, even if nonresponders in terms of forced expiratory volume in one second, may benefit from bronchodilators because they can breathe, still in a flow-limited manner, at a lower lung volume.

This article has been cited by other articles:

				R. L. Dellaca, P. P. Pompilio, P. P. Walker, N. Duffy, A. Pedotti, and P. M. A. Calverley Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD Eur. Respir. J., June 1, 2009; 33(6): 1329 - 1337. [Abstract] [Full Text] [PDF]

				D E O'Donnell, P Laveneziana, J Ora, K A Webb, Y-M Lam, and D Ofir Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD Thorax, March 1, 2009; 64(3): 216 - 223. [Abstract] [Full Text] [PDF]

				B. R. Celli Update on the Management of COPD Chest, June 1, 2008; 133(6): 1451 - 1462. [Abstract] [Full Text] [PDF]

				D. Ofir, P. Laveneziana, K. A. Webb, Y.-M. Lam, and D. E. O'Donnell Mechanisms of Dyspnea during Cycle Exercise in Symptomatic Patients with GOLD Stage I Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 622 - 629. [Abstract] [Full Text] [PDF]

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				R. Walker, J. Paratz, and A. E. Holland Reproducibility of the Negative Expiratory Pressure Technique in COPD Chest, August 1, 2007; 132(2): 471 - 476. [Abstract] [Full Text] [PDF]

				D. E. O'Donnell, R. B. Banzett, V. Carrieri-Kohlman, R. Casaburi, P. W. Davenport, S. C. Gandevia, A. F. Gelb, D. A. Mahler, and K. A. Webb Pathophysiology of Dyspnea in Chronic Obstructive Pulmonary Disease: A Roundtable Proceedings of the ATS, May 1, 2007; 4(2): 145 - 168. [Abstract] [Full Text] [PDF]

				D. E. O'Donnell and P. Laveneziana Physiology and consequences of lung hyperinflation in COPD Eur. Respir. Rev., December 1, 2006; 15(100): 61 - 67. [Abstract] [Full Text] [PDF]

				D. E. O'Donnell and P. Laveneziana Lung hyperinflation in COPD: the impact of pharmacotherapy Eur. Respir. Rev., December 1, 2006; 15(100): 85 - 89. [Abstract] [Full Text] [PDF]

				E. F. M. Wouters Nonpharmacological modulation of dynamic hyperinflation Eur. Respir. Rev., December 1, 2006; 15(100): 90 - 96. [Abstract] [Full Text] [PDF]

				A. E. Holland, L. Denehy, and J. W. Wilson Does expiratory flow limitation predict chronic dyspnoea in adults with cystic fibrosis? Eur. Respir. J., July 1, 2006; 28(1): 96 - 101. [Abstract] [Full Text] [PDF]

				D. E. O'Donnell Is Sustained Pharmacologic Lung Volume Reduction Now Possible in COPD? Chest, March 1, 2006; 129(3): 501 - 503. [Full Text] [PDF]

				B. R. Celli Chronic Obstructive Pulmonary Disease: From Unjustified Nihilism to Evidence-based Optimism. Proceedings of the ATS, January 1, 2006; 3(1): 58 - 65. [Abstract] [Full Text] [PDF]

				C. Casanova, C. Cote, J. P. de Torres, A. Aguirre-Jaime, J. M. Marin, V. Pinto-Plata, and B. R. Celli Inspiratory-to-Total Lung Capacity Ratio Predicts Mortality in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 591 - 597. [Abstract] [Full Text] [PDF]

				P. M. A. Calverley and N. G. Koulouris Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology Eur. Respir. J., January 1, 2005; 25(1): 186 - 199. [Abstract] [Full Text] [PDF]

				D.E. O'Donnell, N. Voduc, M. Fitzpatrick, and K.A. Webb Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Eur. Respir. J., July 1, 2004; 24(1): 86 - 94. [Abstract] [Full Text] [PDF]

				M. Pecchiari, A. Pelucchi, E. D'Angelo, A. Foresi, J. Milic-Emili, and E. D'Angelo Effect of Heliox Breathing on Dynamic Hyperinflation in COPD Patients Chest, June 1, 2004; 125(6): 2075 - 2082. [Abstract] [Full Text] [PDF]

				P M A Calverley Breathlessness during exercise in COPD: how do the drugs work? Thorax, June 1, 2004; 59(6): 455 - 457. [Full Text] [PDF]

				J P Fuldl and M M Cotton Performance enhancement in chronic obstructive pulmonary disease Chronic Respiratory Disease, April 1, 2004; 1(2): 95 - 98. [Abstract] [PDF]

				P.-H. Wang, P.-H. Kuo, C.-L. Hsu, H.-D. Wu, Y.-S. Chang, S.-H. Kuo, and P.-C. Yang Diagnostic Value of Negative Expiratory Pressure for Airway Hyperreactivity Chest, November 1, 2003; 124(5): 1762 - 1767. [Abstract] [Full Text] [PDF]

				N.G. Koulouris, S. Retsou, E. Kosmas, K. Dimakou, K. Malagari, G. Mantzikopoulos, A. Koutsoukou, J. Milic-Emili, and J. Jordanoglou Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis Eur. Respir. J., May 1, 2003; 21(5): 743 - 748. [Abstract] [Full Text] [PDF]

				N. J. Gross Outcome Measurements in COPD: Are We Schizophrenic? Chest, May 1, 2003; 123(5): 1325 - 1327. [Full Text] [PDF]

				V. Alvisi, A. Romanello, M. Badet, S. Gaillard, F. Philit, and C. Guerin Time Course of Expiratory Flow Limitation in COPD Patients During Acute Respiratory Failure Requiring Mechanical Ventilation Chest, May 1, 2003; 123(5): 1625 - 1632. [Abstract] [Full Text] [PDF]

				V. Alvisi, T. Mirkovic, P. Nesme, C. Guerin, and J. Milic-Emili Acute Effects of Hyperoxia on Dyspnea in Hypoxemia Patients With Chronic Airway Obstruction at Rest Chest, April 1, 2003; 123(4): 1038 - 1046. [Abstract] [Full Text] [PDF]

				F. Di Marco, J. Milic-Emili, B. Boveri, P. Carlucci, P. Santus, F. Casanova, M. Cazzola, and S. Centanni Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD Eur. Respir. J., January 1, 2003; 21(1): 86 - 94. [Abstract] [Full Text] [PDF]

				R. Duranti, M. Filippelli, R. Bianchi, I. Romagnoli, R. Pellegrino, V. Brusasco, and G. Scano Inspiratory Capacity and Decrease in Lung Hyperinflation With Albuterol in COPD Chest, December 1, 2002; 122(6): 2009 - 2014. [Abstract] [Full Text] [PDF]

				E Boni, L Corda, D Franchini, P Chiroli, G P Damiani, L Pini, V Grassi, and C Tantucci Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest Thorax, June 1, 2002; 57(6): 528 - 532. [Abstract] [Full Text] [PDF]

				M. F. Newton, D. E. O'Donnell, and L. Forkert Response of Lung Volumes to Inhaled Salbutamol in a Large Population of Patients With Severe Hyperinflation* Chest, April 1, 2002; 121(4): 1042 - 1050. [Abstract] [Full Text] [PDF]

				D. Goetghebeur, D. Sarni, Y. Grossi, C. Leroyer, H. Ghezzo, J. Milic-Emili, and M. Bellet Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis Eur. Respir. J., March 1, 2002; 19(3): 492 - 498. [Abstract] [Full Text] [PDF]

				D.E. O'Donnell, L. Forkert, and K.A. Webb Evaluation of bronchodilator responses in patients with "irreversible" emphysema Eur. Respir. J., December 1, 2001; 18(6): 914 - 920. [Abstract] [Full Text] [PDF]

				J Hadcroft and P M A Calverley Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease Thorax, September 1, 2001; 56(9): 713 - 720. [Abstract] [Full Text] [PDF]

				M.L. Ayers, R. Mejia, J. Ward, T. Lentine, and D.A. Mahler Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD Eur. Respir. J., June 1, 2001; 17(6): 1132 - 1137. [Abstract] [Full Text] [PDF]

				C O'Brien, P J Guest, S L Hill, and R A Stockley Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care Thorax, August 1, 2000; 55(8): 635 - 642. [Abstract] [Full Text]

				C. TAUBE, B. LEHNIGK, K. PAASCH, D. K. KIRSTEN, R. A. JÖRRES, and H. MAGNUSSEN Factor Analysis of Changes in Dyspnea and Lung Function Parameters after Bronchodilation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 216 - 220. [Abstract] [Full Text]

				D. E. O'Donnell Assessment of Bronchodilator Efficacy in Symptomatic COPD : Is Spirometry Useful? Chest, February 1, 2000; 117 (2009): 42S - 47S. [Abstract] [Full Text] [PDF]

				R. Dueck, S. Cooper, D. Kapelanski, H. Colt, and J. Clausen A Pilot Study of Expiratory Flow Limitation and Lung Volume Reduction Surgery* Chest, December 1, 1999; 116(6): 1762 - 1771. [Abstract] [Full Text] [PDF]

				D. E. O'DONNELL, M. LAM, and K. A. WEBB Spirometric Correlates of Improvement in Exercise Performance after Anticholinergic Therapy in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 542 - 549. [Abstract] [Full Text]

				M. Newton, K. A. Webb, D. E. O'Donnell, C. Murariu, H. Ghezzo, J. Milic-Emili, and H. Gauthier Pulmonary embolism--treatment vs nontreatment. Chest, June 1, 1999; 115(6): 1755 - 1755. [Full Text] [PDF]